Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice. | J Clin Invest | 2022 | 35503416 | PubTator, text mining | PubMed |
| Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles. | Hum Gene Ther | 2022 | 35502479 | PubTator, text mining | PubMed |
| POH1/Rpn11/PSMD14: a journey from basic research in fission yeast to a prognostic marker and a druggable target in cancer cells. | Br J Cancer | 2022 | 35501388 | PubTator, text mining | PubMed |
| RNA sequence analysis identified bone morphogenetic protein-2 (BMP2) as a biomarker underlying form deprivation myopia. | Biochem Biophys Rep | 2022 | 35494490 | PubTator, text mining | PubMed |
| Identifying preeclampsia-associated genes using a control theory method. | Brief Funct Genomics | 2022 | 35484822 | PubTator, text mining | PubMed |
| Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. | Nat Chem Biol | 2022 | 35484434 | PubTator, text mining | PubMed |
| New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis. | Circ Res | 2022 | 35482831 | PubTator, text mining | PubMed |
| The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies. | Neuro Oncol | 2022 | 35481923 | PubTator, text mining | PubMed |
| Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives. | Orthop Res Rev | 2022 | 35480068 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva: A Report of Four Cases. | Cureus | 2022 | 35475090 | PubTator, text mining | PubMed |
| Vascular Calcification: New Insights Into BMP Type I Receptor A. | Front Pharmacol | 2022 | 35462911 | PubTator, text mining | PubMed |
| Signaling cascades in the failing heart and emerging therapeutic strategies. | Signal Transduct Target Ther | 2022 | 35461308 | PubTator, text mining | PubMed |
| New Cases of Hypochromic Microcytic Anemia Due to Mutations in the SLC11A2 Gene and Functional Characterization of the G75R Mutation. | Int J Mol Sci | 2022 | 35457224 | PubTator, text mining | PubMed |
| Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts. | Int J Mol Sci | 2022 | 35456903 | PubTator, text mining | PubMed |
| MicroRNA-132-3p, Downregulated in Myeloid Angiogenic Cells from Hereditary Hemorrhagic Telangiectasia Patients, Is Enriched in the TGFβ and PI3K/AKT Signalling Pathways. | Genes (Basel) | 2022 | 35456471 | PubTator, text mining | PubMed |
| Essential Management of Pediatric Brain Tumors. | Children (Basel) | 2022 | 35455542 | PubTator, text mining | PubMed |
| RNA-seq and Mitochondrial DNA Analysis of Adrenal Gland Metastatic Tissue in a Patient with Renal Cell Carcinoma. | Biology (Basel) | 2022 | 35453788 | PubTator, text mining | PubMed |
| Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis. | J Cell Biochem | 2022 | 35442524 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective. | Orphanet J Rare Dis | 2022 | 35436894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=33